Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,555 | -7,609 | 29,821 | -27,909 | -20,520 |
| Depreciation Amortization | 141 | 123 | 571 | 444 | 307 |
| Accounts payable and accrued liabilities | 686 | -226 | -2,110 | -2,016 | -2,079 |
| Other Working Capital | 3,286 | -568 | -4,038 | -3,848 | -5,536 |
| Other Operating Activity | 3,024 | 1,937 | -57,787 | 5,966 | 4,695 |
| Operating Cash Flow | $-9,418 | $-6,343 | $-33,543 | $-27,363 | $-23,133 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 7,000 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $7,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,821 | -1,563 | -3,125 | -1,563 | N/A |
| Common Stock Issued | 77,212 | 10,360 | N/A | N/A | N/A |
| Financing Cash Flow | $67,391 | $8,797 | $-3,125 | $-1,563 | $N/A |
| Beginning Cash Position | 48,944 | 48,944 | 78,612 | 78,612 | 78,612 |
| End Cash Position | 106,917 | 51,398 | 48,944 | 49,686 | 55,479 |
| Net Cash Flow | $57,973 | $2,454 | $-29,668 | $-28,926 | $-23,133 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,418 | -6,343 | -33,543 | -27,363 | -23,133 |
| Free Cash Flow | -9,418 | -6,343 | -33,543 | -27,363 | -23,133 |